Key Documents

View All Documentation

Residual Solvent Class 2 - Acetonitrile

Name: Residual Solvent Class 2 - Acetonitrile
Brand: USP

United States Pharmacopeia (USP) Reference Standard

Synonym(s):

Acetonitrile solution

Select a Size

Change View

Pack Size	SKU	Availability	Price

About This Item

Linear Formula:

CH₃CN

CAS Number:

75-05-8

Molecular Weight:

41.05

UNSPSC Code:

41116107

NACRES:

NA.24

PubChem Substance ID:

329751031

MDL number:

MFCD00001878

Beilstein/REAXYS Number:

4124158

Pricing and availability is not currently available.

Technical Service

Need help? Our team of experienced scientists is here for you.

Let Us Assist

Properties

grade

pharmaceutical primary standard

manufacturer/tradename

USP

density

0.782 g/mL at 25 °C

application(s)

pharmaceutical (small molecule)

format

neat

SMILES string

CC#N

InChI

1S/C2H3N/c1-2-3/h1H3

InChI key

WEVYAHXRMPXWCK-UHFFFAOYSA-N

Description

General description

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Application

Residual Solvent Class 2 - Acetonitrile USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia.

Analysis Note

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.

Other Notes

Sales restrictions may apply.

Compare Similar Items

View Full Comparison

Show Differences

1 of 1

This Item	PHR1320	RTC000080	PHR1551
USP 1601340 Residual Solvent Class 2 - Acetonitrile	Supelco PHR1320 Residual Solvent - Acetonitrile(solution in DMSO)	Supelco RTC000080 Acetonitrile	Supelco PHR1551 Acetonitrile(Neat)
manufacturer/tradename USP	manufacturer/tradename -	manufacturer/tradename -	manufacturer/tradename -
grade pharmaceutical primary standard	grade certified reference material, pharmaceutical secondary standard	grade certified reference material, pharmaceutical secondary standard	grade certified reference material, pharmaceutical secondary standard
format neat	format single component solution	format neat	format neat
application(s) pharmaceutical (small molecule)	application(s) pharmaceutical (small molecule)	application(s) pharmaceutical small molecule	application(s) pharmaceutical (small molecule)
density 0.782 g/mL at 25 °C	density 0.786 g/mL at 25 °C (lit.)	density 0.786 g/mL at 25 °C (lit.)	density 0.786 g/mL at 25 °C (lit.)

Storage Class

10 - Combustible liquids

wgk

WGK 1

flash_point_f

188.6 °F - closed cup

flash_point_c

87 °C - closed cup

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documents section.

If you need assistance, please contact Customer Support

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Analysis of changes in SUMO-2/3 modification during breast cancer progression and metastasis.

Divya Subramonian et al.

Journal of proteome research, 13(9), 3905-3918 (2014-07-30)

SUMOylation is an essential posttranslational modification and regulates many cellular processes. Dysregulation of SUMOylation plays a critical role in metastasis, yet how its perturbation affects this lethal process of cancer is not well understood. We found that SUMO-2/3 modification is

Identification of N-linked glycosylation and putative O-fucosylation, C-mannosylation sites in plasma derived ADAMTS13.

N Sorvillo et al.

Journal of thrombosis and haemostasis : JTH, 12(5), 670-679 (2014-07-01)

Acquired deficiency of ADAMTS13 causes a rare and life-threatening disorder called thrombotic thrombocytopenic purpura (TTP). Several studies have shown that aberrant glycosylation can play an important role in the pathogenesis of autoimmune diseases.N-linked glycosylation and putative O-fucosylation sites have been

Hippocampal Lewy pathology and cholinergic dysfunction are associated with dementia in Parkinson's disease.

Hélène Hall et al.

Brain : a journal of neurology, 137(Pt 9), 2493-2508 (2014-07-27)

The neuropathological substrate of dementia in patients with Parkinson's disease is still under debate, particularly in patients with insufficient alternate neuropathology for other degenerative dementias. In patients with pure Lewy body Parkinson's disease, previous post-mortem studies have shown that dopaminergic

View All Related Papers

Global Trade Item Number

SKU	GTIN
1601340-3X1.2ML	04065271209268
1601340-3AMP	04061838745095

Questions

Reviews

No rating value